-
公开(公告)号:US10562910B2
公开(公告)日:2020-02-18
申请号:US16322945
申请日:2017-08-02
Applicant: SUNSHINE LAKE PHARMA CO., LTD.
Inventor: Xiaojun Wang , Xinye Yang , Junwen Wu , Shaohui Xiong , Shengqiang Pan , Shengtian Cao , Yingjun Zhang
IPC: C07D491/044 , C07D491/056 , A61K31/4164 , A61P9/04 , A61K31/4353 , A61P15/00 , A61P5/50 , A61P9/12 , A61P7/02 , A61P9/10 , A61K31/42 , C07D491/107
Abstract: A nitrogen-containing tricyclic compound which acts as modulator of FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the use of the compound for the treatment of disease and/or condition mediated by FXR are described. And a pharmaceutical composition containing the compound disclosed herein and a method of treatment of disease and/or condition mediated by FXR comprising administering the compound or the pharmaceutical composition thereof are also described.
-
公开(公告)号:US10183917B2
公开(公告)日:2019-01-22
申请号:US15541018
申请日:2016-02-05
Applicant: Sunshine Lake Pharma Co., Ltd.
Inventor: Xiaojun Wang , Xinye Yang , Shengqiang Pan , Rui Guo , Junwen Wu , Yingjun Zhang , Changchung Cheng
IPC: C07D261/08 , C07D249/06 , A61K31/42 , A61K31/4353 , A61K31/4985 , A61K31/519 , C07D411/12 , C07D413/12 , C07D471/04 , C07D491/044 , C07D497/04 , C07D498/14 , C07D491/052 , C07D491/147 , C07D498/04
Abstract: The present invention relates to novel tricyclic compounds which can bind to FXR and act as modulators of the FXR, or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and the uses of the compounds for the treatment of diseases and/or conditions mediated by FXR. The invention further provides a pharmaceutical composition containing the compound disclosed herein and a method of treatment of diseases and/or conditions mediated by FXR comprising administering the compound or the pharmaceutical composition.
-